VirtualScopics Reports Second Quarter 20...(1016 Liabilities and Stockholders' Eq...),Health
1,016
Liabilities and Stockholders' Equity
Current liabilities
Accounts payable and accrued expenses $729,247 $626,693
Accrued payroll 384,109 221,013
Unearned revenue 212,941 279,275
Total current liabilities 1,326,297 1,126,981
Commitments and Contingencies - -
Stockholders' Equity
Preferred stock, $0.001 par value;
15,000,000 shares authorized;
8,400 shares designated Series A;
issued and outstanding: 3,976 at
June 30, 2008, 4,001 at December 31,
2007 4 4
6,000 shares designated Series B;
issued and outstanding: 4,226 at
June 30, 2008, 4,230 at December 31,
2007 4 4
Common Stock, $0.001 par value;
85,000,000 shares authorized; issued
and outstanding: 23,459,852 at June
30, 2008 and 23,225,664 at December
31, 2007 23,460 23,226
Additional paid-in capital 16,266,168 15,616,124
Accumulated deficit (10,360,946) (8,585,323)
Total stockholders' equity 5,928,690 7,054,035
Total liabilities and stockholders'
equity $7,254,987 $8,181,016
CONTACT: Company Contact:
Molly Henderson
Chief Business and Financial Officer
500 Linden Oaks
Rochester, New York 14625
(585)249.6231
'/>"/>
| SOURCE VirtualScopics, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. VirtualScopics Announces $4.35 Million Private Placement
2. VirtualScopics Backlog Exceeds a Record $20 Million
3. VirtualScopics Receives NASDAQ Delisting Notice; Company Files Appeal to Stay Delisting
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |